01
Metabolism and interactions
Assessment of potential interactions involving CYP substrates, inhibitors and inducers.
ENHYDRO SCIENCE / DIGITAL HEALTH
Better insight into medication-related risk.
MediControl is a clinical decision-support software platform developed by Enhydro Science for structured evaluation of potential pharmacological risks in polypharmacy.
Designed to support healthcare professionals. The clinician remains responsible for every therapeutic decision.
PHARMACOLOGICAL RISK ASSESSMENT
Four complementary dimensions.
Evaluation integrates medicine information, interaction mechanisms and clinically relevant patient parameters.
02
Elimination and transporters
Considerations involving renal function, non-CYP pathways and drug transporters.
03
Exposure sensitivity
Contextualization of medicines with different therapeutic-index characteristics.
04
Risk patterns
Potential QT prolongation, bleeding, sedation, hypotension and other clinically relevant pharmacodynamic effects.
PRODUCT DEVELOPMENT
Current product and next-generation platform.
MediControl 1.0 · MDR Class I
Current medical-device software
According to the manufacturer, the Class I version is registered in Italy and supports medication-risk evaluation within its specified intended purpose. It does not autonomously change prescriptions.
MediControl 2.0 · IN DEVELOPMENT
Extended clinical workflows
Development roadmap includes more complex clinical evaluation and follow-up scenarios. A future MDR classification remains subject to the final intended purpose and applicable conformity assessment; no higher classification certification is claimed.
Clinical responsibility: MediControl supports assessment and does not replace clinical judgment, validated prescribing references, or patient-specific evaluation. Product claims and the applicable scope must remain aligned with approved manufacturer documentation.
RESEARCH & PARTNERSHIPS
Discuss a MediControl collaboration.
For healthcare organizations, clinical research groups, digital health partners and EHR providers.
Contact Enhydro Science →